Heron Ther­a­peu­tics launch­es patent suit against My­lan over po­ten­tial gener­ic for chemo-re­lat­ed nau­sea

Heron Ther­a­peu­tics filed suit in Delaware fed­er­al court on Fri­day to block My­lan Phar­ma­ceu­ti­cals’ gener­ic ver­sion of a drug used for chemother­a­py-as­so­ci­at­ed nau­sea.

Heron’s Cin­van­ti …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER